The Center for Neurodegenerative Disease Research (CNDR) 9th Annual Marian S. Ware Research Retreat will be held October 16, 8:30 a.m.-5 p.m. in the Biomedical Research Building II/III Auditorium. This year the retreat will focus on Current Research in Alzheimer Biomarkers.
8:30 a.m.: breakfast buffet in lobby
8:55 a.m.: Opening Remarks, Virginia M.-Y. Lee, director, Center for Neurodegenerative Disease Research
9 a.m.: Holly Soares, Pfizer, Inc., Overview of CSF and Plasma AD Biomarkers
9:30 a.m.: David Holtzman, Washington University School of Medicine, CSF AD Biomarkers: Correlations with imaging and value in diagnosis and prognosis of pre-clinical and early clinical AD
10 a.m.: Randy Bateman, Washington University School of Medicine, Dynamic Changes In CSF Aβ In Healthy Individuals And AD Patients
11 a.m.: Leslie Shaw, Penn Medicine, Validating AD Biomarkers in the AD Neuroimaging Initiative
11:30 a.m.: Harald Hampel, Trinity College, Dublin, Ireland; University of Munich, Germany, Alzheimer Memorial Center, Neurochemical markers of amyloid related mechanisms in AD
2 p.m.: Douglas Galasko, University of California at San Diego, CSF Tau And Aβ Dynamics Over The Lifespan
2:30 p.m.: Tony Wyss-Coray, Stanford University VA Palo Alto Health Care System, Systemic plasma biomarkers for aging and AD
3 p.m.: Daniel Skovronsky, Avid Radiopharmaceuticals, Inc., president and CEO, Aβ Amyloid Imaging Ligands As AD Biomarkers
3:30 p.m.: Christos Davatzikos, Penn Medicine, Integrating Data From Neuroimaging And Chemical AD Biomarkers
Questions? Please call (215) 662-4708.
